A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
about
Antiviral drug resistance: mechanisms and clinical implicationsA multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.Improving the care of patients with genital herpes.Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy.Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementContact dermatitis from topical antiviral drugs.Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.Emerging therapies for herpes viral infections (types 1 - 8).Genital herpes: antiviral therapy for symptom relief and prevention of transmission.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingThalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Common skin conditions in children with HIV/AIDS.Antiviral drug resistance in herpesviruses other than cytomegalovirus.Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.2017 European guidelines for the management of genital herpes.Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir.Potent inhibition of hemangiosarcoma development in mice by cidofovir.Intravenous Foscarnet With Topical Cidofovir for Chronic Refractory Genital Herpes in a Patient With AIDS.2014 UK national guideline for the management of anogenital herpes.Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient.Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy.Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.An unusual vulval lesion in an HIV-infected woman.
P2860
Q28282376-FB0E9860-95FC-414E-A1E9-923CDDCA42AAQ33701865-E1C112FD-886A-4CFE-9AD4-407CA3588A10Q33801850-B8E50604-0464-4A04-A003-F1E6D5D6E91FQ33976018-5596EC45-DC37-4577-AEFD-7525117C12B5Q34035099-66C2C89D-924C-4D32-A488-A7FF29A6E322Q34149904-7E183DAA-34D4-4DD4-836F-D6A0C5B223C9Q34216587-3A2A0B18-35E8-4CA7-B700-560174705A1FQ34459279-EF0DF070-B12E-444A-A4A1-C38B5BDE6BD4Q35558801-25C8CAB4-7919-48AB-88C2-961BC74C4426Q35917125-857E869A-BAB6-4D65-8E20-DE1530A83014Q35967376-54AB72F1-F723-4F71-828D-F7B990EEEB90Q36429709-7584493A-F068-4A48-A9D0-96D0D14DA252Q36630996-481045A8-697A-41C4-AE72-3C7BD2BCB556Q36811460-F108B479-99A3-4704-B41A-E4830EB6E693Q37771396-4EC7C2AD-4187-4333-A5D4-DB66EC88676DQ37992671-472B33E0-AE67-45DE-BB51-D63A8E2FA882Q38194111-A27BA013-D5A3-4EA4-9908-1C3AEB5B8499Q39565488-3F75FF18-3724-47E2-8CF6-2644824E872AQ40072392-F827D7B0-0A05-43CC-B48A-D02DCA95E4ABQ40680195-0E8BF406-81E9-4CEB-8582-CC199D74C35AQ40814289-9D29DC1C-6742-4AF8-B1E9-8868FFFAB620Q40825613-F2F36D03-34CD-4590-9321-53E2101EF950Q41345018-04769E0E-0C97-4F89-B443-F2FC5E51B6EAQ41609436-700E3530-D480-4826-99E7-84D0A6495319Q43513739-7843A871-8A9B-4AC0-92E3-520230EC75A3Q43690814-3BC1D933-C791-4DA5-BA9A-299A334B301EQ43938257-CF7483E3-78DB-4B6A-9261-8F4A5E7AD72FQ45357350-877E64D2-2823-4647-9970-BDFE848E77D5Q46985255-4B0471E6-9FFD-43A9-95F5-CE4986080C35
P2860
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... fection in patients with AIDS.
@en
A randomized, double-blind, pl ...... fection in patients with AIDS.
@nl
type
label
A randomized, double-blind, pl ...... fection in patients with AIDS.
@en
A randomized, double-blind, pl ...... fection in patients with AIDS.
@nl
prefLabel
A randomized, double-blind, pl ...... fection in patients with AIDS.
@en
A randomized, double-blind, pl ...... fection in patients with AIDS.
@nl
P2093
P356
P1476
A randomized, double-blind, pl ...... fection in patients with AIDS.
@en
P2093
J Feinberg
J Lalezari
P304
P356
10.1086/516542
P407
P577
1997-10-01T00:00:00Z